Found: 47
Select item for more details and to access through your institution.
Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study.
- Published in:
- Clinical Genetics, 2008, v. 73, n. 5, p. 430, doi. 10.1111/j.1399-0004.2008.00978.x
- By:
- Publication type:
- Article
Response to Cohen.
- Published in:
- Clinical Genetics, 2007, v. 72, n. 2, p. 161, doi. 10.1111/j.1399-0004.2007.00838.x
- By:
- Publication type:
- Article
The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.
- Published in:
- Clinical Genetics, 2007, v. 71, n. 3, p. 205, doi. 10.1111/j.1399-0004.2007.00769.x
- By:
- Publication type:
- Article
Evaluation of disease burden and response to treatment in adults with type 1 gaucher disease using a validated disease severity scoring system (DS3).
- Published in:
- Orphanet Journal of Rare Diseases, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13023-015-0280-3
- By:
- Publication type:
- Article
Evaluation of disease burden and response to treatment in adults with type 1 Gaucher disease using a validated disease severity scoring system (DS3).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Patients with type 1 Gaucher disease in South Florida, USA: demographics, genotypes, disease severity and treatment outcomes.
- Published in:
- Orphanet Journal of Rare Diseases, 2014, v. 9, n. 1, p. 45, doi. 10.1186/1750-1172-9-45
- By:
- Publication type:
- Article
Patients with type 1 Gaucher disease in South Florida, USA: demographics, genotypes, disease severity and treatment outcomes.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Reducing selection bias in case-control studies from rare disease registries.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Managing chronic nonmalignant pain: overcoming obstacles to the use of opioids.
- Published in:
- 2000
- By:
- Publication type:
- journal article
MRI in the era of nephrogenic systemic fibrosis: review, controversies and suggestions for risk reduction.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: A study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
- Published in:
- Journal of Bone & Mineral Research, 2012, v. 27, n. 8, p. 1839, doi. 10.1002/jbmr.1680
- By:
- Publication type:
- Article
Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 10, p. 1337, doi. 10.1002/ajh.26675
- By:
- Publication type:
- Article
Risk factors for development of obesity in an ethnically diverse CHD population.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Sulfonylurea therapy improves glucose disposal without changing skeletal muscle GLUT4 levels in noninsulin-dependent diabetes mellitus subjects: a longitudinal study.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies.
- Published in:
- 2001
- By:
- Publication type:
- journal article
The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11 , 5158
- Published in:
- 2023
- By:
- Publication type:
- Letter
Cystic renal mass evaluation: real-time versus static imaging.
- Published in:
- 1986
- By:
- Publication type:
- journal article
Ambroxol as Therapy for Gaucher Disease—Ambitious but Ambivalent.
- Published in:
- 2023
- By:
- Publication type:
- Opinion
Safety and effectiveness of taliglucerase alfa in patients with Gaucher disease: an interim analysis of real-world data from a multinational drug registry (TALIAS).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Intensive insulin therapy in critical care: a review of 12 protocols.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Physiologically‐Based Pharmacokinetic Model Development, Validation, and Application for Prediction of Eliglustat Drug–Drug Interactions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1254, doi. 10.1002/cpt.2738
- By:
- Publication type:
- Article
Neurochemical abnormalities in patients with type 1 Gaucher disease on standard of care therapy.
- Published in:
- Journal of Inherited Metabolic Disease, 2020, v. 43, n. 3, p. 564, doi. 10.1002/jimd.12182
- By:
- Publication type:
- Article
Hepatocellular carcinoma in Gaucher disease: an international case series.
- Published in:
- Journal of Inherited Metabolic Disease, 2018, v. 41, n. 5, p. 819, doi. 10.1007/s10545-018-0142-y
- By:
- Publication type:
- Article
Echo-train STIR MRI of the liver: comparison of breath-hold and non-breath-hold imaging strategies.
- Published in:
- 1999
- By:
- Publication type:
- journal article
T2-weighted MR imaging of the chest: comparison of electrocardiograph-triggered conventional and turbo spin-echo and nontriggered turbo spin-echo sequences.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Effect on fetal mouse development of exposure to MR imaging and gadopentetate dimeglumine.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Safety and optimum concentration of a manganese chloride-based oral MR contrast agent.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Quantitative analysis of gadopentetate dimeglumine excreted in breast milk.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Cardiovascular MR imaging: current level of clinical activity.
- Published in:
- 1992
- By:
- Publication type:
- journal article
MR imaging of the abdomen: are we there yet?
- Published in:
- 1991
- By:
- Publication type:
- Editorial
End-Organ Function and Exercise Performance in Patients With Fontan Circulation: What Characterizes the High Performers?
- Published in:
- Journal of the American Heart Association, 2020, v. 9, n. 24, p. 1, doi. 10.1161/JAHA.120.016850
- By:
- Publication type:
- Article
End-Organ Function and Exercise Performance in Patients With Fontan Circulation: What Characterizes the High Performers?
- Published in:
- 2020
- By:
- Publication type:
- journal article
The role of cognitive impairment and caregiver support in diabetes management of older outpatients.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Spinal cord injury models: a review.
- Published in:
- Spinal Cord, 2014, v. 52, n. 8, p. 588, doi. 10.1038/sc.2014.91
- By:
- Publication type:
- Article
Insulin sensitivity in cystic fibrosis.
- Published in:
- 1994
- By:
- Publication type:
- journal article
The history and accomplishments of the ICGG Gaucher registry.
- Published in:
- American Journal of Hematology, 2015, v. 90, p. S2, doi. 10.1002/ajh.24054
- By:
- Publication type:
- Article
Position statement: National Gaucher Foundation Medical Advisory Board, January 7, 2014.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 5, p. 457, doi. 10.1002/ajh.23687
- By:
- Publication type:
- Article
Gaucher disease: Resetting the clinical and scientific agenda.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 4, p. 205, doi. 10.1002/ajh.21384
- By:
- Publication type:
- Article
Life expectancy in Gaucher disease type 1.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 12, p. 896, doi. 10.1002/ajh.21305
- By:
- Publication type:
- Article
Guidance on the use of miglustat for treating patients with type 1 Gaucher disease.
- Published in:
- American Journal of Hematology, 2005, v. 80, n. 3, p. 223, doi. 10.1002/ajh.20504
- By:
- Publication type:
- Article
Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4-5 years.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 4, p. 528, doi. 10.1111/j.1365-2141.2012.09175.x
- By:
- Publication type:
- Article
Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis.
- Published in:
- British Journal of Haematology, 2009, v. 147, n. 4, p. 561, doi. 10.1111/j.1365-2141.2009.07872.x
- By:
- Publication type:
- Article
Interruption in enzyme replacement therapy for gaucher disease.
- Published in:
- British Journal of Haematology, 2001, v. 113, n. 4, p. 1087, doi. 10.1046/j.1365-2141.2001.02821-11.x
- By:
- Publication type:
- Article
Gaucher disease – more than just a rare lipid storage disease.
- Published in:
- Journal of Molecular Medicine, 2022, v. 100, n. 4, p. 499, doi. 10.1007/s00109-021-02174-z
- By:
- Publication type:
- Article
Pelvic arteriovenous malformations: gadolinium-enhanced three-dimensional MR angiography findings.
- Published in:
- European Radiology, 2000, v. 10, n. 8, p. 1257, doi. 10.1007/s003300000329
- By:
- Publication type:
- Article
Debility, unspecified: A terminal diagnosis.
- Published in:
- American Journal of Hospice & Palliative Medicine, 1996, v. 13, n. 6, p. 38, doi. 10.1177/104990919601300614
- By:
- Publication type:
- Article